Literature DB >> 28438965

Radiation induces proinflammatory dysbiosis: transmission of inflammatory susceptibility by host cytokine induction.

Shiran Gerassy-Vainberg1,2, Alexandra Blatt1, Yael Danin-Poleg2, Katya Gershovich1, Edmond Sabo3, Alex Nevelsky4, Shahar Daniel4, Aviva Dahan1, Oren Ziv5, Rishu Dheer6, Maria T Abreu6, Omry Koren5, Yechezkel Kashi2, Yehuda Chowers1.   

Abstract

OBJECTIVE: Radiation proctitis (RP) is a complication of pelvic radiotherapy which affects both the host and microbiota. Herein we assessed the radiation effect on microbiota and its relationship to tissue damage using a rectal radiation mouse model.
DESIGN: We evaluated luminal and mucosa-associated dysbiosis in irradiated and control mice at two postradiation time points and correlated it with clinical and immunological parameters. Epithelial cytokine response was evaluated using bacterial-epithelial co-cultures. Subsequently, germ-free (GF) mice were colonised with postradiation microbiota and controls and exposed to radiation, or dextran sulfate-sodium (DSS). Interleukin (IL)-1β correlated with tissue damage and was induced by dysbiosis. Therefore, we tested its direct role in radiation-induced damage by IL-1 receptor antagonist administration to irradiated mice.
RESULTS: A postradiation shift in microbiota was observed. A unique microbial signature correlated with histopathology. Increased colonic tumor necrosis factor (TNF)α, IL-1β and IL-6 expression was observed at two different time points. Adherent microbiota from RP differed from those in uninvolved segments and was associated with tissue damage. Using bacterial-epithelial co-cultures, postradiation microbiota enhanced IL-1β and TNFα expression compared with naïve microbiota. GF mice colonisation by irradiated microbiota versus controls predisposed mice to both radiation injury and DSS-induced colitis. IL-1 receptor antagonist administration ameliorated intestinal radiation injury.
CONCLUSIONS: The results demonstrate that rectal radiation induces dysbiosis, which transmits radiation and inflammatory susceptibility and provide evidence that microbial-induced radiation tissue damage is at least in part mediated by IL-1β. Environmental factors may affect the host via modifications of the microbiome and potentially allow for novel interventional approaches via its manipulation. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.

Entities:  

Keywords:  COLONIC MICROFLORA; CYTOKINES; INFLAMMATION; RADIATION THERAPY

Mesh:

Substances:

Year:  2017        PMID: 28438965     DOI: 10.1136/gutjnl-2017-313789

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  66 in total

1.  Potential of Omega-3 Polyunsaturated Fatty Acids in Managing Chemotherapy- or Radiotherapy-Related Intestinal Microbial Dysbiosis.

Authors:  Yue Zhang; Boyan Zhang; Lihua Dong; Pengyu Chang
Journal:  Adv Nutr       Date:  2019-01-01       Impact factor: 8.701

Review 2.  A review of cancer immunotherapy: from the past, to the present, to the future.

Authors:  K Esfahani; L Roudaia; N Buhlaiga; S V Del Rincon; N Papneja; W H Miller
Journal:  Curr Oncol       Date:  2020-04-01       Impact factor: 3.677

Review 3.  Gut microbiome, big data and machine learning to promote precision medicine for cancer.

Authors:  Giovanni Cammarota; Gianluca Ianiro; Anna Ahern; Carmine Carbone; Andriy Temko; Marcus J Claesson; Antonio Gasbarrini; Giampaolo Tortora
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-07-09       Impact factor: 46.802

Review 4.  Gut commensal bacteria, Paneth cells and their relations to radiation enteropathy.

Authors:  Yan-Li Gao; Li-Hong Shao; Li-Hua Dong; Peng-Yu Chang
Journal:  World J Stem Cells       Date:  2020-03-26       Impact factor: 5.326

5.  Chronic rhinosinusitis in elderly patients is associated with an exaggerated neutrophilic proinflammatory response to pathogenic bacteria.

Authors:  Justin C Morse; Ping Li; Kim A Ely; Meghan H Shilts; Todd J Wannemuehler; Li-Ching Huang; Quanhu Sheng; Naweed I Chowdhury; Rakesh K Chandra; Suman R Das; Justin H Turner
Journal:  J Allergy Clin Immunol       Date:  2018-11-22       Impact factor: 10.793

6.  Murine Genetic Background Has a Stronger Impact on the Composition of the Gut Microbiota than Maternal Inoculation or Exposure to Unlike Exogenous Microbiota.

Authors:  Hila Korach-Rechtman; Shay Freilich; Shiran Gerassy-Vainberg; Keren Buhnik-Rosenblau; Yael Danin-Poleg; Haim Bar; Yechezkel Kashi
Journal:  Appl Environ Microbiol       Date:  2019-08-29       Impact factor: 4.792

7.  The effects of N-acetylcysteine on radiotherapy-induced small intestinal damage in rats.

Authors:  Filiz Mercantepe; Atilla Topcu; Sema Rakici; Levent Tumkaya; Adnan Yilmaz
Journal:  Exp Biol Med (Maywood)       Date:  2019-02-20

8.  Matrix metalloproteinase expression is altered in the small and large intestine following fractionated radiation in vivo.

Authors:  Romany L Stansborough; Noor Al-Dasooqi; Emma H Bateman; Joanne M Bowen; Dorothy M K Keefe; Richard M Logan; Ann S J Yeoh; Eric E K Yeoh; Andrea M Stringer; Rachel J Gibson
Journal:  Support Care Cancer       Date:  2018-05-12       Impact factor: 3.603

9.  Methionine dietary supplementation potentiates ionizing radiation-induced gastrointestinal syndrome.

Authors:  Isabelle R Miousse; Laura E Ewing; Charles M Skinner; Rupak Pathak; Sarita Garg; Kristy R Kutanzi; Stepan Melnyk; Martin Hauer-Jensen; Igor Koturbash
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2020-01-21       Impact factor: 4.052

10.  A comparative analysis of gut microbiota disturbances in the Gottingen minipig and rhesus macaque models of acute radiation syndrome following bioequivalent radiation exposures.

Authors:  Franck Carbonero; Alba C Mayta-Apaza; Jiang-Zhou Yu; Matt Lindeblad; Alex Lyubimov; Flavia Neri; Erzsebet Szilagyi; Amelia Bartholomew
Journal:  Radiat Environ Biophys       Date:  2018-10-20       Impact factor: 1.925

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.